摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-hydroxy-9H-benzo[c]indolo[3,2,1-ij]-1,5-naphthyridin-9-one

中文名称
——
中文别名
——
英文名称
5-hydroxy-9H-benzo[c]indolo[3,2,1-ij]-1,5-naphthyridin-9-one
英文别名
5-hydroxy-9H-benzo[c]indolo[3,2,1-ij][1,5]naphthyridin-9-one;5-hydroxy-1,11-diazapentacyclo[10.7.1.02,7.08,20.013,18]icosa-2(7),3,5,8(20),9,11,13,15,17-nonaen-19-one
5-hydroxy-9H-benzo[c]indolo[3,2,1-ij]-1,5-naphthyridin-9-one化学式
CAS
——
化学式
C18H10N2O2
mdl
MFCD08284232
分子量
286.29
InChiKey
ULANNPMYNRXRCC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    55.1
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • SPECIFIC INHIBITORS OF PROTEIN P21 AS THERAPEUTIC AGENTS
    申请人:Baden-Württemberg Stiftung gGmbH
    公开号:EP2895462A1
    公开(公告)日:2015-07-22
  • [EN] SPECIFIC INHIBITORS OF PROTEIN P21 AS THERAPEUTIC AGENTS<br/>[FR] INHIBITEURS SPÉCIFIQUES DE LA PROTÉINE P21 COMME AGENTS THÉRAPEUTIQUES
    申请人:BADEN WUERTTEMBERG STIFTUNG GMBH
    公开号:WO2014041125A1
    公开(公告)日:2014-03-20
    The present invention relates to novel inhibitors of p21. These inhibitors are useful as therapeutic agents for promoting cell regeneration and in the treatment of cancer. Improvement of cell regeneration is particularly desirable in patients of old age or in patients suffering from chronic diseases, acute or chronic injuries.
查看更多

同类化合物

长春考酯 长春曲尔 铁屎米酮N氧化物 铁屎米酮 苦木西碱Q 温可纳特 9-羟基铁屎米酮 9-甲氧基铁屎米酮N氧化物 9-甲氧基-6H-吲哚并[3,2,1-De][1,5]萘啶-6-酮 9,10-二甲氧基铁屎米酮 7,14-二苯基二吲哚并[3,2,1-去:3',2',1'-ij][1,5]萘啶-6,13-二酮 5-羟基-6-铁屎米酮 5-羟基-4-甲氧基铁屎米酮 5-甲氧基铁屎米酮 4,5-二甲氧基铁屎米酮 11-羟基-6H-吲哚并[3,2,1-de][1,5]萘啶-6-酮 11-甲基-20,21-二去甲埃那美宁 10-羟基-6H-吲哚并[3,2,1-de][1,5]萘啶-6-酮 1-羟基-6-铁屎米酮 1,2,3,3a,4,5-六氢铁屎米酮 1,2,3,3a,4,5-六氢-3-甲基-6H-吲哚并(3,2,1-de)(1,5)萘啶-6-酮单甲烷磺酸盐 1,2,3,3a,4,5-六氢-3-乙基-6H-吲哚并(3,2,1-de)(1,5)萘啶-6-酮 (3S,16S)-17alpha,21-环氧-14,15-二氢-14alpha-羟基-12-甲氧基埃那美宁-14-羧酸甲酯 3,4,5,6-Tetradehydrotalbotin 4,5,6,7-tetrachloro-2-(3,7-dimethyl-14-oxo-14H-benzo[4,5]isoquino[2,1-b]benzo[ij][2,7]naphthyridin-5-yl)-indan-1,3-dione (1S,17S,21R)-18-oxa-4,14-diazahexacyclo[9.9.2.01,17.04,22.05,10.014,21]docosa-5,7,9,11(22)-tetraen-3-one 5-chloro-6-methyl-indolo[3,2,1-de][1,5]naphthyridin-4-one 3-Butyl-1,2,3,3a,4,5-hexahydro-6-canthinon 10-Chlor-3-aethyl-1,2,3,3a,4,5-hexahydro-6-canthinon 3-Ethyl-10-methyl-1,2,3,3a,4,5-hexahydro-6-canthinon 5,5-dibromo-6-methyl-5,6-dihydro-indolo[3,2,1-de][1,5]naphthyridin-4-one 2-hydroxymethyl-3-prop-2-ynyl-1,2,3,3a,4,5-hexahydro-indolo[3,2,1-de][1,5]naphthyridin-6-one 3-isobutyl-1,2,3,3a,4,5-hexahydro-indolo[3,2,1-de][1,5]naphthyridin-6-one 5-(9-Trimethylsilanyl-2,3,4,9-tetrahydro-1H-β-carbolin-1-yl)-6,7-dihydro-5H-[2]pyrindine-4-carbonitrile 5-Methyl-9-methoxy-6,7,12,13-tetrahydro-6,12-methylimino-5H-benzo<5.6>cyclooct<1.2-b>indol (12aS,12bR)-2,3,4,5,11,12,12a,12b-Octahydro-3a,9b-diaza-benzo[a]naphtho[2,1,8-cd]azulene-1,10-dione 19,20-Dihydrotalbotin ent-17β,21-epoxy-12-methoxy-14,15-dihydro-eburnamenin-14β-ol 15H-20,21-dinor-eburnamenine-14,17-dione larutenine ethyl 11-ethyl-11,12-dihydro-7-methyl-12-oxobenzo[a]pyrrolo[2,1-c][4,7]phenanthroline-6-carboxylate cimilophytine ethyl 11,12-dihydro-7,11-dimethyl-12-oxobenzo[a]-pyrrolo[2,1-c][4,7]phenanthroline-6-carboxylate (19E)-17β-methoxy-4-methyl-talbotin-19-en-23-oic acid methyl ester (19E)-17β-methoxy-talbotin-19-en-23-oic acid methyl ester (19E)-17β-acetoxy-4-acetyl-talbotin-19-en-23-oic acid methyl ester (19E)-17β-methoxy-4-methyl-talbotin-19-en-23-ol 4-((propan-2-ylideneaminooxy)methyl)-5,6-dihydroazepino[3,2,1-jk]carbazol-7(4H)-one dimethyl 4-hydroxy-4,7-dihydro-3,7a-diazacyclohepta[jk]fluorene-2,5-dicarboxylate Cuanzine